Q32 Bio Inc. · NASDAQ:QTTB
Orbimed Advisors LLC reported a 13.90% stake in Q32 Bio Inc. (Schedule 13D/A)
Event Jul 16, 2026 · Filed Jul 20, 2026
Orbimed Advisors LLC reported a 13.90% stake in Q32 Bio Inc., 4,127,987 shares, with active intent on Jul 16, 2026. Filed Jul 20, 2026 (Schedule 13D/A).
- Stake
- 13.90%
- Shares
- 4,127,987
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 13.90% | 4,127,987 |
| ORBIMED CAPITAL GP VII LLC | 11.80% | 3,502,987 |
| OrbiMed Genesis GP LLC | 2.10% | 625,000 |
Source
Related
- Q32 Bio Inc.
- Orbimed Advisors LLC
- Q32 Bio Inc. shareholders
- Schedule 13D/A · Orbimed Advisors LLC · Jun 1, 2026
- Schedule 13D/A · Orbimed Advisors LLC · May 6, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Mar 12, 2026
- Form 4 · Morrison Jodie Pope · Oct 14, 2026
- Form 4 · Violette Shelia M. · Oct 14, 2026
- Form 4 · Kalowski Lee · Oct 14, 2026
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Oct 9, 2026
- Form 4 · Morrison Jodie Pope · Aug 27, 2026